Main Content
  • University of Maryland School of Medicine Professor Receives Benjamin Franklin Award for Open Access in the Life Sciences

    Owen White, PhD, Professor of Epidemiology and Public Health and Associate Director of Informatics at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine as well as Co-Director of the UM Center for Health-related Informatics and Bioimaging (CHIB), has been selected to receive the Benjamin Franklin Award for Open Access in the Life Sciences from Bioinformatics.org, also known as the Bioinformatics Organization.


  • Innovative Prevention Program in East Africa Seeks to Ensure Access to Care for Addicts with HIV

    Heroin addiction is a growing problem in Kenya and Tanzania. Both countries are key transit points in the international heroin trade, and in recent years, increasing numbers of people in both countries are becoming addicted.


  • New Research Sheds Light on How Popular Probiotic Benefits the Gut

    Researchers at the University of Maryland School of Medicine have come up with an explanation for why a common gut microbe may be beneficial to our health. It appears that microbe may act as a facilitator, modifying the activity of other gut bacteria. This is the first time this mechanism has been described; the discovery could eventually help scientists create more effective strategies to foster a healthy gut.


  • Dr. Elijah Saunders, 80, University of Maryland School of Medicine Icon, Pioneer and Legendary Cardiologist, Passes On

    University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today, with deep sadness, the passing of one of the legendary figures in the School of Medicine and University’s history: Elijah Saunders, MD, FACC, FACP, FAHA, FASH, Professor of Medicine and Head of the Section of Hypertension in the School’s Division of Cardiovascular Medicine.


  • University of Maryland School of Medicine Plans to Launch Major New Global Health and Vaccine Institute; Building on Longstanding Worldwide Leadership in Malaria Research and Vaccine Development

    University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that the School of Medicine (UM SOM) plans to establish a major new Institute for Global Health (IGH), bringing together decades of UM SOM research, treatment and vaccine development around the world, and expanding the School’s platform as the premier, leading center for global health research, treatment and prevention. The new Institute will focus on vaccine development and malaria research, and will house the UM SOM’s reconfigured Center for Vaccine Development (CVD) as well as a newly-formed Center for Malaria Research (CMR).


  • University of Maryland Medicine Announces New National Program In Lung Healing to Develop Innovative Approaches for Preventing and Treating Acute Lung Disease

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new “Program in Lung Healing,” that will further the School’s position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.


News Archive » Submit News » RSS
Publication Archives »

State of the School School of Medicine Rankings Meet Our Students Make a Difference - Make a Gift